MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


TOP NEWS: Relx expects more growth as boosted by face-to-face activity

ALN

Relx PLC on Thursday revealed an improved year-to-date performance across all units, with business at its Exhibitions unit surging due to more people visiting its venues.

The London-based business and scientific information provider predicted annual growth in revenue and earnings for 2022.

Relx reported underlying revenue growth of 9% for the first nine months of 2022, higher than 6% a year ago. Full year underlying growth rates in revenue and adjusted operating profit, as well as constant currency growth in adjusted earnings per share, remain "above historical trends".

The Exhibitions unit outshone other units as it grew 85% in underlying revenue, boosted by face-to-face activity across most geographies. A year ago, it grew by 9% as exhibition venues slowly started to reopen across the Relx's geographies following the Covid-19 pandemic.

The second strongest grower was its Risk unit with a 7% increase, albeit weaker than its 10% growth a year prior. Relx said growth during the year so far was helped by an improved Insurance growth run-rate from the half-year started June 30 onwards.

Legal underlying revenue increased by 5%, stronger than 3% a year ago, as Relx cited positive momentum for new sales and continued strong renewals.

Within Scientific, Technical & Medical, underlying revenue grew 4%, the same as a year ago, driven by a higher number of submitted and published articles via Primary Research. The underlying growth rate is calculated at constant currencies and excluding results of acquisitions until 12 months after purchase.

Relx shares were up 0.2% at 2,227.37 pence each in London late Thursday morning.

Copyright 2022 Alliance News Limited. All Rights Reserved.